Fabrizio Carta

Prof. Fabrizio Carta

University of Florence
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 April 2011 in Cancer Research
Verified
Journal Article
Closed access
PDF file
YLYuanmei Lou
Yuanmei Lou
PMPaul C. McDonald
Paul C. McDonald
AOArusha Oloumi
Arusha Oloumi
SCStephen Chia
Stephen Chia
COChristina Ostlund
Christina Ostlund
SDShoukat Dedhar
Shoukat Dedhar
Carbonic anhydrase IX (CAIX) is a hypoxia and HIF-1–inducible protein that regulates intra- and extracellular pH under hypoxic conditions and promotes tumor cell survival and invasion in hypoxic microenvironments. Interrogation of 3,630 human breast cancers provided definitive evidence of CAIX as an independent poor prognostic biomarker for distant metastases and survival. shRNA-mediated depletion of CAIX expression in 4T1 mouse metastatic breast cancer cells capable of inducing CAIX in hypoxia resulted in regression of orthotopic mammary tumors and inhibition of spontaneous lung metastasis formation. Stable depletion of CAIX in MDA-MB-231 human breast cancer xenografts also resulted in attenuation of primary tumor growth. CAIX depletion in the 4T1 cells led to caspase-independent cell death and reversal of extracellular acidosis under hypoxic conditions in vitro. Treatment of mice harboring CAIX-positive 4T1 mammary tumors with novel CAIX-specific small molecule inhibitors that mimicked the effects of CAIX depletion in vitro resulted in significant inhibition of tumor growth and metastasis formation in both spontaneous and experimental models of metastasis, without inhibitory effects on CAIX-negative tumors. Similar inhibitory effects on primary tumor growth were observed in mice harboring orthotopic tumors comprised of lung metatstatic MDA-MB-231 LM2-4Luc+ cells. Our findings show that CAIX is vital for growth and metastasis of hypoxic breast tumors and is a specific, targetable biomarker for breast cancer metastasis. Cancer Res; 71(9); 3364–76. ©2011 AACR.

1 March 2011 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
FPFabio Pacchiano
Fabio Pacchiano
FCFabrizio Carta
Fabrizio Carta
PMPaul C. McDonald
Paul C. McDonald
YLYuanmei Lou
Yuanmei Lou
DVDaniela Vullo
Daniela Vullo
Claudiu SupuranClaudiu Supuran
Claudiu Supuran

6 March 2013 in Expert Opinion on Therapeutic Patents
Verified
Journal Article
Closed access
EMEmanuela Masini
Emanuela Masini
FCFabrizio Carta
Fabrizio Carta
ASAndrea Scozzafava
Andrea Scozzafava
Claudiu SupuranClaudiu Supuran
Claudiu Supuran
Introduction: Glaucoma is one of the major causes of blindness, affecting together with age-related macular degeneration > 70 million people worldwide. One of the therapeutic options for its manage...

6 March 2013 in Expert Opinion on Therapeutic Patents
Verified
Journal Article
Closed access
FCFabrizio Carta
Fabrizio Carta
Claudiu SupuranClaudiu Supuran
Claudiu Supuran
Introduction: The benzothiadiazines and high ceiling diuretics (hydrochlorothiazide, hydroflumethiazide, quinethazone, metolazone, chlorthalidone, indapamide, furosemide and bumetanide) contain pri...

6 March 2013 in Expert Opinion on Therapeutic Patents
Verified
Journal Article
Closed access
ASAndrea Scozzafava
Andrea Scozzafava
Claudiu SupuranClaudiu Supuran
Claudiu Supuran
FCFabrizio Carta
Fabrizio Carta
Introduction: Obesity is ranked as one of the top 10 global health problems and the major concern deriving from it is the exposure of the population to a vast array of chronic pathologies such as c...

10 April 2018 in Medicinal Research Reviews
Verified
Journal Article
Closed access
PDF file
Claudiu SupuranClaudiu Supuran
Claudiu Supuran
VINCENZO ALTERIOVINCENZO ALTERIO
VINCENZO ALTERIO
AFAnna Di Fiore
Anna Di Fiore
KAKatia D’ Ambrosio
Katia D’ Ambrosio
FCFabrizio Carta
Fabrizio Carta
Giuseppina  De SimoneGiuseppina De Simone
Giuseppina De Simone